A new analysis indicates that the average duration of drug shortages in Europe is expected to reach 5.3 years by 2025, surpassing the 4.3 years recorded in 2024.
This trend raises significant concerns about the accessibility of medications and the implications for healthcare systems.
U.S. authorities are reportedly increasing their focus on European drug pricing, which may further complicate the landscape for pharmaceutical availability.